相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molnupiravir: A new candidate for COVID-19 treatment
Fariba Pourkarim et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2022)
Molnupiravir and Its Antiviral Activity Against COVID-19
Lili Tian et al.
FRONTIERS IN IMMUNOLOGY (2022)
Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication
Kim M. Stegmann et al.
ISCIENCE (2022)
A Systematic Study on the Optimal Nucleotide Analogue Concentration and Rate Limiting Nucleotide of the SARS-CoV-2 RNA-Dependent RNA Polymerase
Hasan Vatandaslar
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide synthesis
Chao Qin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19
James F. Demarest et al.
ANTIVIRAL RESEARCH (2022)
Ribavirin and cellular ribavirin-triphosphate concentrations in blood and bronchoalveolar lavage fluid in two lung transplant patients with respiratory syncytial virus
Scott W. Mueller et al.
TRANSPLANT INFECTIOUS DISEASE (2021)
Efficacy of ribavirin and interferon-? therapy for hospitalized patients with COVID-19: A multicenter, retrospective cohort study
Hui Li et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Structural basis for isoform-specific inhibition of human CTPS1
Eric M. Lynch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses
Nicola Borbone et al.
MOLECULES (2021)
Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
β-D-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
Shuntai Zhou et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Profiling Ribonucleotide and Deoxyribonucleotide Pools Perturbed by Remdesivir in Human Bronchial Epithelial Cells
Yan Li et al.
FRONTIERS IN PHARMACOLOGY (2021)
Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
Florian Kabinger et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)
Incorporation efficiency and inhibition mechanism of 2′-substituted nucleotide analogs against SARS-CoV-2 RNA-dependent RNA polymerase
Congmin Yuan et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2021)
Asunaprevir, a Potent Hepatitis C Virus Protease Inhibitor, Blocks SARS-CoV-2 Propagation
Yun-Sook Lim et al.
MOLECULES AND CELLS (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
Abdo A. Elfiky
LIFE SCIENCES (2020)
The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future
Jin-Yan Li et al.
MICROBES AND INFECTION (2020)
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Guangdi Li et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Coupled structural transitions enable highly cooperative regulation of human CTPS2 filaments
Eric M. Lynch et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cytosine drives evolution of SARS-CoV-2
Antoine Danchin et al.
ENVIRONMENTAL MICROBIOLOGY (2020)
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19
Jahan S. Khalili et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment
Luigi Buonaguro et al.
INFECTIOUS AGENTS AND CANCER (2020)
Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov
Haiping Zhang et al.
INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control
Yosra A. Helmy et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Ribavirin therapy for severe COVID-19: a retrospective cohort study
Song Tong et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Viperin Reveals Its True Function
Efrain E. Rivera-Serrano et al.
ANNUAL REVIEW OF VIROLOGY, VOL 7, 2020 (2020)
Mechanistic cross-talk between DNA/RNA polymerase enzyme kinetics and nucleotide substrate availability in cells: Implications for polymerase inhibitor discovery
Si'Ana A. Coggins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19
Minchen Chien et al.
JOURNAL OF PROTEOME RESEARCH (2020)
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
Abdo A. Elfiky
LIFE SCIENCES (2020)
Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic
Rodrigo Jacome et al.
SCIENTIFIC REPORTS (2020)
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
Anahita Sadeghi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Drug repurposing approach to fight COVID-19
Thakur Uttam Singh et al.
PHARMACOLOGICAL REPORTS (2020)
Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review
Rami A. Al-Horani et al.
VIRUSES-BASEL (2020)
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
Xuping Xie et al.
NATURE COMMUNICATIONS (2020)
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir
Steffen Jockusch et al.
SCIENTIFIC REPORTS (2020)
Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2
Manisha Prajapat et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2020)
A Path toward SARS-CoV-2 Attenuation: Metabolic Pressure on CTP Synthesis Rules the Virus Evolution
Zhihua Ou et al.
GENOME BIOLOGY AND EVOLUTION (2020)
Nucleotide analogues as inhibitors of SARS-CoV Polymerase
Jingyue Ju et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2020)
The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection
George R. Painter et al.
ANTIVIRAL RESEARCH (2019)
Drosophila CTP synthase can form distinct substrate- and product-bound filaments
Xian Zhou et al.
JOURNAL OF GENETICS AND GENOMICS (2019)
Small-Molecule Antiviral β-D-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance
Maria L. Agostini et al.
JOURNAL OF VIROLOGY (2019)
Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia
Mart Toots et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
β-D-N4-Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome
Nadya Urakova et al.
JOURNAL OF VIROLOGY (2018)
Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C Virus
Darius Babusis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses
Jeong-Joong Yoon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
A tRNA's fate is decided at its 3′ end: Collaborative actions of CCA-adding enzyme and RNases involved in tRNA processing and degradation
Karolin Wellner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2018)
Biophysical Analysis of Bacterial CTP Synthase Filaments Formed in the Presence of the Chemotherapeutic Metabolite Gemcitabine-5'-triphosphate
Gregory D. McCluskey et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
Pinching the ammonia tunnel of CTP synthase unveils coordinated catalytic and allosteric-dependent control of ammonia passage
Gregory D. McCluskey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2018)
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo(2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses
Dustin Siegel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Human CTP synthase filament structure reveals the active enzyme conformation
Eric M. Lynch et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Human CTP synthase filament structure reveals the active enzyme conformation
Eric M. Lynch et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Exploring the Potent Inhibition of CTP Synthase by Gemcitabine-5′-Triphosphate
Gregory D. McCluskey et al.
CHEMBIOCHEM (2016)
Sofosbuvir in the Treatment of Chronic Hepatitis C: New Dog, New Tricks
George M. Abraham et al.
CLINICAL INFECTIOUS DISEASES (2014)
Large-scale filament formation inhibits the activity of CTP synthetase
Rachael M. Barry et al.
ELIFE (2014)
Identification of novel filament-forming proteins in Saccharomyces cerevisiae and Drosophila melanogaster
Chalongrat Noree et al.
JOURNAL OF CELL BIOLOGY (2010)
The metabolic enzyme CTP synthase forms cytoskeletal filaments
Michael Ingerson-Mahar et al.
NATURE CELL BIOLOGY (2010)
The mechanism of action of β-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidme involves a second metabolic pathway leading to β-D-2'-deoxy-2-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymerase
Eisuke Murakami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Structural requirements for the activation of Escherichia coli CTP synthase by the allosteric effector GTP are stringent, but requirements for inhibition are lax
Faylene A. Lunn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Characterization of the metabolic activation of hepatitis C virus nucleoside inhibitor β-D-2′-Deoxy-2′-fluoro-2′-C-methylcytidine (PSI-6130) and identification of a novel active 5′-triphosphate species
Han Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Metabolic and molecular aspects of ethanolamine phospholipid biosynthesis:: the role of CTP:phosphoethanolamine cytidylyltransferase (Pcyt2)
Marica Bakovic et al.
BIOCHEMISTRY AND CELL BIOLOGY (2007)
Mechanism of activation of β-D-2′-deoxy-2′-fluoro-2′-C-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymerase
Eisuke Murakami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Structure of the synthetase domain of human CTP synthetase, a target for anticancer therapy
Petri Kursula et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2006)
The role of lysine residues 297 and 306 in nucleoside triphosphate regulation of E-coli CTP synthase:: Inactivation by 2′,3′-dialdehyde ATP and mutational analyses
TJ MacLeod et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2006)
Mechanisms of action of ribavirin against distinct viruses
JD Graci et al.
REVIEWS IN MEDICAL VIROLOGY (2006)
Mechanisms of product feedback regulation and drug resistance in cytidine triphosphate synthetases from the structure of a CTP-inhibited complex
JA Endrizzi et al.
BIOCHEMISTRY (2005)
Competition between ammonia derived from internal glutamine hydrolysis and hydroxylamine present in the solution for incorporation into UTP as catalysed by Lactococcus lactis CTP synthase
M Willemoës
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Inhibitors of CTP biosynthesis potentiate the anti-human immunodeficiency virus type 1 activity of 3TC in activated peripheral blood mononuclear cells
N Dereuddre-Bosquet et al.
ANTIVIRAL RESEARCH (2004)
Crystal structure of Escherichia coli cytidine triphosphate synthetase, a nucleotide-regulated glutamine amidotransferase/ATP-dependent amidoligase fusion protein and homologue of anticancer and antiparasitic drug targets
JA Endrizzi et al.
BIOCHEMISTRY (2004)
Aspartate-107 and leucine-109 facilitate efficient coupling of glutamine hydrolysis to CTP synthesis by Escherichia coli CTP synthase
A Iyengar et al.
BIOCHEMICAL JOURNAL (2003)
Ribonucleoside analogue that blocks replication of bovine viral diarrhea and hepatitis C viruses in culture
LJ Stuyver et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines
CJA van Moorsel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2000)
Potentiation of the anti-HIV activity of zalcitabine and lamivudine by a CTP synthase inhibitor, 3-deazauridine
WY Gao et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2000)
分享论文
